Precigen (PGEN) Net Margin (2012 - 2026)
Precigen (PGEN) posted quarterly Net Margin of 34.1% for Q1 2026, up 400415.0% year-over-year from N/an in Q1 2025, and up 88.59% quarter-over-quarter from 298.79% in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Net Margin (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Net Margin for 14 consecutive years, with 34.1% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin rose 400415.0% year-over-year to 34.1%; the TTM figure through Mar 2026 stood at 1167.5% (up 155732.0% YoY), while the FY2025 annual figure was 4436.62%, down 122044.0% from the prior year.
- Net Margin grew to 34.1% in Q1 2026 per PGEN's latest filing, from 298.79% in the prior quarter.
- Across five years, Net Margin topped out at 649.77% in Q3 2022 and bottomed at 2397800.0% in Q3 2024.
- Historically, Net Margin has averaged 204171.65% across 4 years, with a median of 1381.76% in 2024.
- On a YoY basis, Net Margin climbed as much as 236326242 bps in 2025 and fell as far as 180933 bps in 2025.
- Precigen's Net Margin stood at 649.77% in 2022, then tumbled by 182 bps to 534.61% in 2024, then jumped by 44 bps to 298.79% in 2025, then jumped by 89 bps to 34.1% in 2026.
- Business Quant data shows PGEN's Net Margin at 34.1% in Q1 2026, 298.79% in Q4 2025, and 34537.58% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 36.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.51% |
| Mar 31, 2026 | -34.10% |
| Dec 31, 2025 | -514.85% |
| Sep 30, 2025 | -11,134.29% |
| Jun 30, 2025 | -3,112.38% |
| Mar 31, 2025 | -4,038.26% |
| Dec 31, 2024 | -1,657.73% |
| Sep 30, 2024 | -2,516.05% |
| Jun 30, 2024 | -8,199.72% |
| Mar 31, 2024 | -2,228.92% |
| Dec 31, 2023 | -2,691.86% |
| Sep 30, 2023 | -1,435.46% |
| Jun 30, 2023 | -1,149.92% |
| Mar 31, 2023 | -1,228.20% |
| Dec 31, 2022 | -1,257.86% |
| Sep 30, 2022 | 522.54% |
| Jun 30, 2022 | -605.81% |
| Mar 31, 2022 | -349.19% |
| Dec 31, 2021 | -679.53% |
| Sep 30, 2021 | -893.01% |